EE9800388A - Chlamydia psittaci´t sisaldavad kassivaktsiinid ja nende valmistamismeetod - Google Patents

Chlamydia psittaci´t sisaldavad kassivaktsiinid ja nende valmistamismeetod

Info

Publication number
EE9800388A
EE9800388A EE9800388A EE9800388A EE9800388A EE 9800388 A EE9800388 A EE 9800388A EE 9800388 A EE9800388 A EE 9800388A EE 9800388 A EE9800388 A EE 9800388A EE 9800388 A EE9800388 A EE 9800388A
Authority
EE
Estonia
Prior art keywords
preparation
vaccines containing
chlamydia psittaci
containing chlamydia
cat
Prior art date
Application number
EE9800388A
Other languages
English (en)
Other versions
EE04516B1 (et
Inventor
A. Atherton Rebecca
Schmeer Norbert
A. Hallstrom Jean
K. Lane Jennifer
J. Hennessy Kristina
Original Assignee
Bayer Corporation
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corporation, Bayer Aktiengesellschaft filed Critical Bayer Corporation
Publication of EE9800388A publication Critical patent/EE9800388A/et
Publication of EE04516B1 publication Critical patent/EE04516B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EE9800388A 1996-05-06 1997-04-21 Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod EE04516B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,673 US5972350A (en) 1996-05-06 1996-05-06 Feline vaccines containing Chlamydia psittaci and method for making the same
PCT/US1997/007514 WO1997041889A1 (en) 1996-05-06 1997-04-21 Feline vaccines containing chlamydia psittaci and method for making the same

Publications (2)

Publication Number Publication Date
EE9800388A true EE9800388A (et) 1999-06-15
EE04516B1 EE04516B1 (et) 2005-08-15

Family

ID=24581818

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800388A EE04516B1 (et) 1996-05-06 1997-04-21 Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod

Country Status (16)

Country Link
US (1) US5972350A (et)
EP (1) EP0904106A1 (et)
JP (1) JP2000510121A (et)
AU (1) AU717628B2 (et)
BG (1) BG63564B1 (et)
BR (1) BR9708975A (et)
CA (1) CA2203234A1 (et)
CZ (1) CZ297848B6 (et)
EE (1) EE04516B1 (et)
IL (1) IL126628A (et)
NO (1) NO320871B1 (et)
NZ (1) NZ332620A (et)
PL (1) PL329734A1 (et)
SK (1) SK149198A3 (et)
TR (1) TR199802259T2 (et)
WO (1) WO1997041889A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010048927A1 (en) * 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
CN100423775C (zh) * 2005-04-15 2008-10-08 中国农业科学院兰州兽医研究所 牛衣原体病灭活疫苗及其制备与检验方法
CA2681183A1 (en) * 2007-05-30 2008-12-11 Wyeth Raccoon poxvirus expressing genes of feline antigens
FR3039406B1 (fr) * 2015-07-28 2020-09-18 Centre Nat Rech Scient Composition vaccinale contre les infections a chlamydiaceae

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
CN1134112A (zh) * 1993-11-03 1996-10-23 辉瑞大药厂 衣原体感染的疫苗及治疗方法

Also Published As

Publication number Publication date
WO1997041889A1 (en) 1997-11-13
MX9703278A (es) 1998-05-31
CZ360498A3 (cs) 1999-03-17
CA2203234A1 (en) 1997-11-06
US5972350A (en) 1999-10-26
JP2000510121A (ja) 2000-08-08
PL329734A1 (en) 1999-04-12
IL126628A (en) 2002-09-12
AU2996297A (en) 1997-11-26
BG63564B1 (bg) 2002-05-31
BG102890A (en) 1999-09-30
TR199802259T2 (xx) 1999-02-22
BR9708975A (pt) 1999-08-03
NO985172L (no) 1999-01-06
NO320871B1 (no) 2006-02-06
CZ297848B6 (cs) 2007-04-11
EE04516B1 (et) 2005-08-15
IL126628A0 (en) 1999-08-17
SK149198A3 (en) 2000-02-14
EP0904106A1 (en) 1999-03-31
NO985172D0 (no) 1998-11-05
AU717628B2 (en) 2000-03-30
NZ332620A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
EE03976B1 (et) Erütromütsiinid ja nende valmistamise meetod
EE04540B1 (et) Meetod bioloogiliselt sobivate biodegradeeruvate mikroosakeste valmistamiseks ja mikroosakeste kasutamine
BR9607726A (pt) Dispositivo e método para retração de tecido gengival
FI973750A0 (fi) 2-metyylitienobentsodiatsepiinin valmistus ja kiteiset muodot
FI97726C (fi) Sulatyöstettävä polyesteriuretaani ja menetelmä sen valmistamiseksi
PL330416A1 (en) Method of and composition for lighting up human hair
EE03742B1 (et) Tramadooli mitmikühikulised preparaadid ja nende valmistamismeetod
FI963185A (fi) Hematopoieettinen proteiini ja materiaalit ja menetelmät sen valmistamiseksi
MX164146B (es) Sistema y metodo para la preparacion de alimentos
FI951340A0 (fi) SOI-substraatti ja menetelmä sen valmistamiseksi
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
PT854880E (pt) Novos derivados de 5-o-desosaminil 6-o-metil eritronolido a metodo para a sua preparacao e a sua utilizacao na preparacao de produtos biologicamente activos
EE9800119A (et) Mikrokapseldatud putukamürgi preparaadid ja protsess nende valmistamiseks
EE9800161A (et) Vähivaktsiin ja selle valmistamismeetod
KR960007649A (ko) 공중합 폴리아미드 및 그의 제조방법
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
FI952229A (fi) Kuumuutta kestävä hiusvalmiste ja menetelmä sen käyttämiseksi
ATE232360T1 (de) Antibiotischer cocktail und verwendungsverfahren
BR9605702A (pt) Alourante para cabelos humanos
EE9800388A (et) Chlamydia psittaci´t sisaldavad kassivaktsiinid ja nende valmistamismeetod
FR2732343B1 (fr) Composition de maltitol et son procede de preparation
FR2746261B1 (fr) Composition insecticide et procede de preparation
FR2630306B1 (fr) Cheveu artificiel et son procede de preparation
DE69524527D1 (de) AIDS-hemmende Arzneizubereitung und Verfahren
FI940403A (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20080421